logo
  • Nonprofit News
  • Management
    • Boards and Governance
    • Communication
      • Framing & Narratives
    • Ethics
    • Financial Management
    • Fund Development
    • Leadership
    • Technology
  • Philanthropy
    • Corporate Social Responsibility
    • Donor-Advised Funds
    • Foundations
    • Impact Investing
    • Research
    • Workplace Giving
  • Policy
    • Education
    • Healthcare
    • Housing
    • Government
    • Taxes
  • Economic Justice
    • Economy Remix
    • Economy Webinars
    • Community Benefits
    • Economic Democracy
    • Environmental Justice
    • Fair Finance
    • Housing Rights
    • Land Justice
    • Poor People’s Rights
    • Tax Fairness
  • Racial Equity
  • Social Movements
    • Community Development
    • Community Organizing
    • Culture Change
    • Education
    • Environment
    • Gender Equality
    • Immigrant Rights
    • Indigenous Rights
    • Labor
    • LGBTQ+
    • Racial Justice
    • Youth Activism
  • About Us
  • Log in
  • CONTENT TYPES
  • Webinars
    • Leading Edge Membership
    • Sponsored Webinars
    • Economic Justice
  • Tiny Spark Podcast
  • Magazine
    • Magazine
    • Leading Edge Membership
Donate
Mental Health, Methadone/Safe Injection Clinics

High-Profile Nonprofit Opioid Advocacy Group Secretly Funded by Pharmaceutical Company

Ruth McCambridge
March 6, 2017
Share2K
Tweet26
Share411
Email
2K Shares
“Patrick J. Kennedy” By United States Congress [Public domain], via Wikimedia Commons

March 5, 2017; Boston Globe

Last week, NPQ covered a research study that showed that eight out of ten patient advocacy groups were funded by pharmaceutical companies, raising questions of conflict of interest in that those advocacy groups both lobby (purportedly on behalf of the patients) and recommend treatments. Now, the Boston Globe has revealed that Advocates for Opioid Recovery, a new advocacy group which includes as paid spokespeople former congressmen Newt Gingrich and Patrick Kennedy, is being secretly backed by a drug company that is pushing for more government funding and insurance coverage of the kinds of treatments that company produces. This turn of events may be enormously disappointing for the mental health and substance abuse advocacy communities who depended upon Kennedy in part to carry an advocacy leadership position in the bipartisan campaign for mental health insurance parity.

In the past, Gingrich denied knowing who funded Advocates for Opioid Recovery, and the nonprofit refused to disclose its funders. But new documents filed with the SEC show that the funder is Braeburn Pharmaceuticals. In those documents, Braeburn disclosed a $900,000 charitable pledge to Advocates for Opioid Recovery, making the donation through the private equity fund that owns Braeburn. That same fund invests in CleanSlate Addiction Treatment Centers, where Kennedy is a board member.

Reporter David Armstrong writes, “While there is widespread support in the treatment community for use of the medicines being promoted…there is growing concern about misuse of the drugs.” This, of course, is exactly why such relationships are a danger to public safety, especially when they are secret.—Ruth McCambridge

Share2K
Tweet26
Share411
Email
2K Shares

About The Author
Ruth McCambridge

Ruth is Editor in Chief of the Nonprofit Quarterly. Her background includes forty-five years of experience in nonprofits, primarily in organizations that mix grassroots community work with policy change. Beginning in the mid-1980s, Ruth spent a decade at the Boston Foundation, developing and implementing capacity building programs and advocating for grantmaking attention to constituent involvement.

Related
Philanthropy as Reciprocity
By Sarah Kastelic
December 2, 2019
Racial Disparities in Pain Prescriptions Kept Thousands of Black Patients Alive
By Steve Dubb
November 26, 2019
Celebrating Our Strengths: Authentic Partnerships for Nation Building
By Valerie Segrest and Lisa Wilson
November 25, 2019
Irrational Numbers: Charting a New Path in Indian Country
By Michael E. Roberts
November 18, 2019
Unions vs. the Human Rights of People with Disabilities: An Ugly Conflict
By Ruth McCambridge
November 15, 2019
Let’s Talk about Fundraising: A Perspective from Cochiti Pueblo
By Trisha Moquino
November 11, 2019
other posts by The Author
Speculations on the Roots of the Loss of Small U.S. Donors:...
By Ruth McCambridge
December 6, 2019
Houston United Way in its Own Crunch Does “Critical...
By Ruth McCambridge
December 6, 2019
A Bookstore Goes to the Museum: Mad Collaborations that Make...
By Ruth McCambridge
December 6, 2019
A Series on Sensemaking Organizations
The Sensemaking Organization: Designing for Complexity
The Sensemaking Mindset: Improvisation over Strategy
Structuring for Sensemaking: The Power of Small Segments
logo
Donate
  • About
  • Contact
  • Newsletters
  • Write for NPQ
  • Advertise
  • Writers
  • Funders
  • Copyright Policy
  • Privacy Policy

Subscribe to View Webinars

We are using cookies to give you the best experience on our website.

 

Non Profit News | Nonprofit Quarterly
Powered by GDPR plugin
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.